Discussion in 'Infections: Lyme, Candida, EBV ...' started by Andy, Mar 19, 2020.
Open access, https://www.nature.com/articles/s41598-020-59600-4
There are a lot of people suffering from chronic Lyme Disease who are banking on Azlocillin being a silver bullet cure. I am pretty skeptical.
I am really unclear as to why Azlocillin was chosen in this study, besides the fact that the researchers have a patent for its reformulation into an oral drug.
There are probably a lot of compounds that will eradicate Bb in vitro. Remember, Disulfiram was said to do this as well, and it's already available for use. But there are a lot of people who remain sick, with some evidence of persistent infection, despite a course of Dilsulfiram.
There are a lot of remaining questions for those of us suffering with chronic effects of tick borne infections and I am dubious that Azlocillin is going to change much.
Separate names with a comma.